Trial Profile
A trial of certolizumab pegol in patients with rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Certolizumab pegol (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 11 Dec 2015 New trial record